Drug profile · INN
sotalol hydrochloride
SORINE
- US status
- approved
- Patents linked
- 5
- News articles
- 0
Quick answer
sotalol hydrochloride (SORINE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12410442
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
granted -
US 11771671
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, Meniere's disease, Tourette's syndrome, attention deficit hyperactivity disorder and addiction
granted -
US 10653652
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction
granted -
US 6649621
Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
expired -
US 6177434
Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
expired
Frequently asked questions
What is sotalol hydrochloride?
sotalol hydrochloride (SORINE) is an FDA-listed pharmaceutical active ingredient. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sotalol hydrochloride?
SORINE is a marketed brand name for sotalol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sotalol hydrochloride?
sotalol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.